Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Thorax Retrieve available abstracts of 92 articles: HTML format

Single Articles

July 2021
1. ARAGHI M, Fidler-Benaoudia M, Arnold M, Rutherford M, et al
   International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
   Thorax. 2021 Jul 19. pii: thoraxjnl-2020-216555.
   PubMed     Abstract available
   
   
   June 2021
2. KRAMER T, Wijmans L, de Bruin M, van Leeuwen T, et al
   Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.
   Thorax. 2021 Jun 25. pii: thoraxjnl-2021-216885.
   PubMed     Abstract available
   
   
   May 2021
3. ZENG L, Xu Q, Yang N, Lizaso A, et al
   Third left pulmonary lobe.
   Thorax. 2021;76:525.
   PubMed    
   
   
   April 2021
4. NASR E, MacRae S, Dobson M, Russell D, et al
   A rare condition masquerading as lung cancer.
   Thorax. 2021 Apr 26. pii: thoraxjnl-2020-216689.
   PubMed    
   
   
   
5. VISSER S, Koolen S, van Donk N, van Walree N, et al
   Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer.
   Thorax. 2021 Apr 15. pii: thoraxjnl-2020-216504.
   PubMed     Abstract available
   
   
   
6. KIM YW, Kwon BS, Lim SY, Lee YJ, et al
   Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
   Thorax. 2021 Apr 15. pii: thoraxjnl-2020-215107.
   PubMed     Abstract available
   
   
   March 2021
7. HONG H, Hahn S, Matsuguma H, Inoue M, et al
   Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis.
   Thorax. 2021 Mar 15. pii: thoraxjnl-2020-216492.
   PubMed     Abstract available
   
   
   February 2021
8. TAN VSR, Li A, Seet JE, Lee P, et al
   Metastases from tracheal adenoid cystic carcinoma.
   Thorax. 2021;76:208-209.
   PubMed    
   
   
   January 2021
9. HOPKINS RJ, Duan F, Gamble GD, Chiles C, et al
   Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers.
   Thorax. 2021 Jan 8. pii: thoraxjnl-2020-214839.
   PubMed     Abstract available
   
   
   December 2020
10. CHRISTIANI DC
    The oral microbiome and lung cancer risk.
    Thorax. 2020 Dec 14. pii: thoraxjnl-2020-216385.
    PubMed    
    
    
    
11. HOSGOOD HD, Cai Q, Hua X, Long J, et al
    Variation in oral microbiome is associated with future risk of lung cancer among never-smokers.
    Thorax. 2020 Dec 14. pii: thoraxjnl-2020-215542.
    PubMed     Abstract available
    
    
    
12. KOYAUCHI T, Suzuki Y, Sato K, Hozumi H, et al
    Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
    Thorax. 2020 Dec 9. pii: thoraxjnl-2020-215917.
    PubMed     Abstract available
    
    
    November 2020
13. CARTER-HARRIS L
    Hidden in plain sight: psychological barriers to participation in lung cancer screening.
    Thorax. 2020 Nov 2. pii: thoraxjnl-2020-216191.
    PubMed    
    
    
    
14. KANELLAKIS NI, Asciak R, Hamid MA, Yao X, et al
    Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.
    Thorax. 2020;75:1004-1008.
    PubMed     Abstract available
    
    
    October 2020
15. KUMMER S, Waller J, Ruparel M, Duffy SW, et al
    Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
    Thorax. 2020 Oct 21. pii: thoraxjnl-2020-215054.
    PubMed     Abstract available
    
    
    
16. FIELD JK, Vulkan D, Davies MPA, Duffy SW, et al
    Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation.
    Thorax. 2020 Oct 20. pii: thoraxjnl-2020-215158.
    PubMed     Abstract available
    
    
    
17. FREISLING H, Seyed Khoei N, Viallon V, Wagner KH, et al
    Gilbert's syndrome, circulating bilirubin and lung cancer: a genetic advantage?
    Thorax. 2020 Oct 6. pii: thoraxjnl-2020-215642.
    PubMed    
    
    
    
18. TAVEIRA-DASILVA AM, Johnson SR, Julien-Williams P, Johnson J, et al
    Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.
    Thorax. 2020;75:904-907.
    PubMed     Abstract available
    
    
    September 2020
19. FARAHI N, Gillett D, Southwood M, Rassl D, et al
    Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT.
    Thorax. 2020 Sep 4. pii: thoraxjnl-2020-214642.
    PubMed     Abstract available
    
    
    
20. BOUJIBAR F, Gillibert A, Gravier FE, Gillot T, et al
    Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis.
    Thorax. 2020;75:791-797.
    PubMed     Abstract available
    
    
    
21. NISHIKAWA Y, Nishiyama O, Shimizu S, Sano A, et al
    Wandering pulmonary shadows coinciding with pericardial and pleural effusions.
    Thorax. 2020;75:817-818.
    PubMed    
    
    
    August 2020
22. HORSFALL LJ, Burgess S, Hall I, Nazareth I, et al
    Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank.
    Thorax. 2020 Aug 27. pii: thoraxjnl-2020-214756.
    PubMed     Abstract available
    
    
    
23. HORST C, Dickson JL, Tisi S, Ruparel M, et al
    Delivering low-dose CT screening for lung cancer: a pragmatic approach.
    Thorax. 2020 Aug 13. pii: thoraxjnl-2020-215131.
    PubMed    
    
    
    
24. RUPAREL M, Quaife SL, Dickson JL, Horst C, et al
    Lung Screen Uptake Trial: results from a single lung cancer screening round.
    Thorax. 2020 Aug 5. pii: thoraxjnl-2020-214703.
    PubMed     Abstract available
    
    
    July 2020
25. BALDWIN D, O'Dowd E, Ten Haaf K
    Targeted screening for lung cancer is here but who do we target and how?
    Thorax. 2020 Jul 6. pii: thoraxjnl-2020-215156.
    PubMed    
    
    
    
26. LEBRETT MB, Balata H, Evison M, Colligan D, et al
    Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme.
    Thorax. 2020 Jul 6. pii: thoraxjnl-2020-214626.
    PubMed     Abstract available
    
    
    June 2020
27. SACHS E, Jackson V, Sartipy U
    Household disposable income and long-term survival after pulmonary resections for lung cancer.
    Thorax. 2020 Jun 20. pii: thoraxjnl-2019-214321.
    PubMed     Abstract available
    
    
    May 2020
28. BALATA H, Harvey J, Barber PV, Colligan D, et al
    Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Thorax. 2020 May 22. pii: thoraxjnl-2019-213584.
    PubMed     Abstract available
    
    
    
29. CRAWLEY D, Breen RA, Elkington PT, Karapanagiotou E, et al
    Tuberculosis associated with Triplet therapy for lung cancer.
    Thorax. 2020 May 14. pii: thoraxjnl-2019-213913.
    PubMed     Abstract available
    
    
    April 2020
30. PARK HY, Kang D, Shin SH, Yoo KH, et al
    Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.
    Thorax. 2020 Apr 2. pii: thoraxjnl-2019-213732.
    PubMed     Abstract available
    
    
    
31. BALDWIN DR, Gustafson J, Pickup L, Arteta C, et al
    External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules.
    Thorax. 2020;75:306-312.
    PubMed     Abstract available
    
    
    March 2020
32. GROVER H, Ross T, Fuller E
    Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography.
    Thorax. 2020 Mar 3. pii: thoraxjnl-2019-214303.
    PubMed     Abstract available
    
    
    January 2020
33. HILEY C, Salem A, Batchelor T, McDonald F, et al
    Great debate: surgery versus stereotactic radiotherapy for early-stage non-small cell lung cancer.
    Thorax. 2020 Jan 21. pii: thoraxjnl-2019-214014.
    PubMed    
    
    
    December 2019
34. KHAKWANI A, Harden S, Beckett P, Baldwin D, et al
    Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.
    Thorax. 2019 Dec 26. pii: thoraxjnl-2018-212493.
    PubMed     Abstract available
    
    
    November 2019
35. ZHANG Z, Zhu D, Cui B, Ding R, et al
    Association between particulate matter air pollution and lung cancer.
    Thorax. 2019 Nov 14. pii: thoraxjnl-2019-213722.
    PubMed     Abstract available
    
    
    September 2019
36. RUPAREL M, Quaife SL, Dickson JL, Horst C, et al
    Evaluation of cardiovascular risk in a lung cancer screening cohort.
    Thorax. 2019 Sep 26. pii: thoraxjnl-2018-212812.
    PubMed     Abstract available
    
    
    
37. FISK M, Bolton CE
    Is targeted lung cancer screening an opportune time to address cardiovascular risk?
    Thorax. 2019 Sep 26. pii: thoraxjnl-2019-213790.
    PubMed    
    
    
    
38. BALATA H, Tonge J, Barber PV, Colligan D, et al
    Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
    Thorax. 2019 Sep 3. pii: thoraxjnl-2018-212601.
    PubMed     Abstract available
    
    
    July 2019
39. O'DOWD EL, Ten Haaf K
    Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results.
    Thorax. 2019 Jul 30. pii: thoraxjnl-2019-213156.
    PubMed    
    
    
    June 2019
40. PEZZELLA F
    Early squamous cell lung carcinoma: prognostic biomarkers for the many.
    Thorax. 2019;74:527-528.
    PubMed    
    
    
    
41. WINTER A, Aberle DR, Hsu W
    External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.
    Thorax. 2019;74:551-563.
    PubMed     Abstract available
    
    
    May 2019
42. STEINER MC
    Should pulmonary rehabilitation be a standard of care in lung cancer?
    Thorax. 2019 May 15. pii: thoraxjnl-2019-213157.
    PubMed    
    
    
    
43. EDBROOKE L, Aranda S, Granger CL, McDonald CF, et al
    Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial.
    Thorax. 2019 May 2. pii: thoraxjnl-2018-212996.
    PubMed     Abstract available
    
    
    
44. HORST C, Nair A, Janes SM
    Lessons on managing pulmonary nodules from NELSON: we have come a long way.
    Thorax. 2019;74:427-429.
    PubMed    
    
    
    April 2019
45. BRIMS F, Gunatilake S, Lawrie I, Marshall L, et al
    Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.
    Thorax. 2019;74:354-361.
    PubMed     Abstract available
    
    
    
46. MARTINEZ-TERROBA E, Behrens C, Agorreta J, Monso E, et al
    5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
    Thorax. 2019;74:371-379.
    PubMed     Abstract available
    
    
    March 2019
47. RAGHU VK, Zhao W, Pu J, Leader JK, et al
    Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Thorax. 2019 Mar 12. pii: thoraxjnl-2018-212638.
    PubMed     Abstract available
    
    
    
48. ZHANG S, Zhang S, Zhang W, He J, et al
    Pulmonary inflammatory myofibroblastic tumour and IgG4-related disease presenting with lower limb paralysis.
    Thorax. 2019;74:313-314.
    PubMed    
    
    
    February 2019
49. ROGERS TK
    Minimising diagnostic delay in lung cancer.
    Thorax. 2019 Feb 23. pii: thoraxjnl-2018-212927.
    PubMed    
    
    
    
50. BARCLAY ME, Lyratzopoulos G, Walter FM, Jefferies S, et al
    Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.
    Thorax. 2019 Feb 18. pii: thoraxjnl-2018-212456.
    PubMed     Abstract available
    
    
    
51. YONG PC, Sigel K, de-Torres JP, Mhango G, et al
    The effect of radiographic emphysema in assessing lung cancer risk.
    Thorax. 2019 Feb 5. pii: thoraxjnl-2018-212457.
    PubMed     Abstract available
    
    
    
52. ZHANG J, Dong A, Cui Y, Wang Y, et al
    Diffuse cavitary benign metastasising leiomyoma of the lung.
    Thorax. 2019;74:208-209.
    PubMed    
    
    
    
53. ONG P, Grosu HB, Debiane L, Casal RF, et al
    Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction.
    Thorax. 2019;74:141-156.
    PubMed     Abstract available
    
    
    January 2019
54. ADIZIE JB, Khakwani A, Beckett P, Hubbard R, et al
    Impact of organisation and specialist service delivery on lung cancer outcomes.
    Thorax. 2019 Jan 19. pii: thoraxjnl-2018-212588.
    PubMed     Abstract available
    
    
    
55. EMERY JD, Murray SR, Walter FM, Martin A, et al
    The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.
    Thorax. 2019 Jan 10. pii: thoraxjnl-2018-212506.
    PubMed     Abstract available
    
    
    December 2018
56. WALTER JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, et al
    Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Thorax. 2018 Dec 27. pii: thoraxjnl-2018-212152.
    PubMed     Abstract available
    
    
    November 2018
57. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.
    Thorax. 2018 Nov 12. pii: thoraxjnl-2018-212547.
    PubMed     Abstract available
    
    
    
58. METS OM, Schaefer-Prokop CM, de Jong PA
    Primary lung cancer in patients with previous malignancies: a nationwide study.
    Thorax. 2018 Nov 1. pii: thoraxjnl-2018-211891.
    PubMed     Abstract available
    
    
    
59. VIS DC, Kelly MM, Lee AG, Gelfand G, et al
    Contralateral recurrence of inflammatory myofibroblastic tumour of the lung 10 years after pneumonectomy.
    Thorax. 2018;73:1089-1090.
    PubMed    
    
    
    October 2018
60. POWELL HA
    Socioeconomic deprivation and inequalities in lung cancer: time to delve deeper?
    Thorax. 2018 Oct 31. pii: thoraxjnl-2018-212362.
    PubMed    
    
    
    August 2018
61. BELOT A, Fowler H, Njagi EN, Luque-Fernandez MA, et al
    Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.
    Thorax. 2018 Aug 12. pii: thoraxjnl-2017-211395.
    PubMed     Abstract available
    
    
    
62. PEAKE MD, Navani N, Baldwin DR
    The continuum of screening and early detection, awareness and faster diagnosis of lung cancer.
    Thorax. 2018 Aug 10. pii: thoraxjnl-2018-212189.
    PubMed    
    
    
    June 2018
63. FIELD JK, Duffy SW
    Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?
    Thorax. 2018 Jun 28. pii: thoraxjnl-2018-211814.
    PubMed    
    
    
    
64. KENNEDY MPT, Cheyne L, Darby M, Plant P, et al
    Lung cancer stage-shift following a symptom awareness campaign.
    Thorax. 2018 Jun 27. pii: thoraxjnl-2018-211842.
    PubMed     Abstract available
    
    
    
65. KIM CH, Jeong JS, Kim SR, Lee YC, et al
    Endobronchial epithelial-myoepithelial carcinoma of the lung.
    Thorax. 2018;73:593-594.
    PubMed    
    
    
    May 2018
66. CHUNG K, Mets OM, Gerke PK, Jacobs C, et al
    Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population.
    Thorax. 2018 May 18. pii: thoraxjnl-2017-211372.
    PubMed     Abstract available
    
    
    April 2018
67. ATHEY VL, Walters SJ, Rogers TK
    Symptoms at lung cancer diagnosis are associated with major differences in prognosis.
    Thorax. 2018 Apr 17. pii: thoraxjnl-2018-211596.
    PubMed     Abstract available
    
    
    
68. WALTER JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, et al
    Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Thorax. 2018 Apr 16. pii: thoraxjnl-2017-211376.
    PubMed     Abstract available
    
    
    
69. XU KF, Tian X, Yang Y, Zhang H, et al
    Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage.
    Thorax. 2018;73:308-310.
    PubMed    
    
    
    March 2018
70. SCHREUDER A, Schaefer-Prokop CM, Scholten ET, Jacobs C, et al
    Lung cancer risk to personalise annual and biennial follow-up computed tomography screening.
    Thorax. 2018 Mar 30. pii: thoraxjnl-2017-211107.
    PubMed     Abstract available
    
    
    
71. MOLLER H, Coupland VH, Tataru D, Peake MD, et al
    Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.
    Thorax. 2018 Mar 6. pii: thoraxjnl-2017-210710.
    PubMed     Abstract available
    
    
    
72. WOOLHOUSE I, Maskell NA
    Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.
    Thorax. 2018;73:210-212.
    PubMed    
    
    
    
73. LI R, Li X, Xue R, Yang F, et al
    Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs).
    Thorax. 2018;73:290-292.
    PubMed    
    
    
    February 2018
74. CROSBIE PA, Balata H, Evison M, Atack M, et al
    Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.
    Thorax. 2018 Feb 13. pii: thoraxjnl-2017-211377.
    PubMed     Abstract available
    
    
    
75. TEN HAAF K, van der Aalst CM, de Koning HJ
    Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening.
    Thorax. 2018 Feb 9. pii: thoraxjnl-2017-211149.
    PubMed    
    
    
    
76. BRUSTLE K, Zachariassen K, Vrugt B, Frauenfelder T, et al
    Acute pulmonary embolism and multiple pulmonary nodules mimicking metastatic disease.
    Thorax. 2018;73:193-194.
    PubMed    
    
    
    January 2018
77. MA C, Frosch ZA, Overmoyer B, Cooper AZ, et al
    Vocal fold paralysis on positron emission tomography-CT.
    Thorax. 2018;73:97-98.
    PubMed    
    
    
    
78. DANTAS GC, Shoji H, Hoelz C, Funari MBG, et al
    Herpes simplex lesion mimicking left upper lobe bronchial tumour.
    Thorax. 2018;73:94-95.
    PubMed    
    
    
    November 2017
79. HJELMBORG J, Korhonen T, Holst K, Skytthe A, et al
    Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer.
    Thorax. 2017;72:1021-1027.
    PubMed     Abstract available
    
    
    October 2017
80. LUCHTENBORG M, Morris EJA, Tataru D, Coupland VH, et al
    Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
    Thorax. 2017 Oct 27. pii: thoraxjnl-2017-210362.
    PubMed     Abstract available
    
    
    
81. HEUVELMANS MA, Walter JE, Vliegenthart R, van Ooijen PMA, et al
    Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.
    Thorax. 2017 Oct 22. pii: thoraxjnl-2017-210770.
    PubMed     Abstract available
    
    
    
82. KALE MS, Sigel K, Mhango G, Wisnivesky JP, et al
    Assessing the extent of non-aggressive cancer in clinically detected stage I non-small cell lung cancer.
    Thorax. 2017 Oct 20. pii: thoraxjnl-2017-210309.
    PubMed     Abstract available
    
    
    September 2017
83. SAITOH Y, Ohnishi-Amemiya A, Asano M, Tanaka Y, et al
    Unique radiological features of two cases of primary pulmonary diffuse large B-cell lymphoma.
    Thorax. 2017;72:859-860.
    PubMed    
    
    
    August 2017
84. MENGOLI MC, Rossi G, Tiseo M, Barbieri F, et al
    'Turban-like' skull metastasis from pulmonary adenocarcinoma.
    Thorax. 2017;72:767-768.
    PubMed    
    
    
    July 2017
85. LOCOCO F, Cardillo G, Veronesi G
    Does a lung cancer screening programme promote smoking cessation?
    Thorax. 2017 Jul 26. pii: thoraxjnl-2017-210621.
    PubMed    
    
    
    
86. CALLISTER ME, Janes SM
    Defining the path: lung cancer CT screening in Europe.
    Thorax. 2017 Jul 19. pii: thoraxjnl-2017-210268.
    PubMed    
    
    
    
87. BRAIN K, Carter B, Lifford KJ, Burke O, et al
    Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
    Thorax. 2017 Jul 14. pii: thoraxjnl-2016-209690.
    PubMed     Abstract available
    
    
    
88. WATSON N
    Radiation exposure during lung cancer diagnostic work-up: how important in the wider picture?
    Thorax. 2017 Jul 5. pii: thoraxjnl-2017-210360.
    PubMed    
    
    
    April 2017
89. RINTOUL RC, Atherton R, Tweed K, Yates S, et al
    Exposure of patients to ionising radiation during lung cancer diagnostic work-up.
    Thorax. 2017 Apr 25. pii: thoraxjnl-2016-209641.
    PubMed     Abstract available
    
    
    
90. PACI E, Puliti D, Lopes Pegna A, Carrozzi L, et al
    Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Thorax. 2017 Apr 4. pii: thoraxjnl-2016-209825.
    PubMed     Abstract available
    
    
    March 2017
91. YOUSAF-KHAN U, van der Aalst C, de Jong PA, Heuvelmans M, et al
    Risk stratification based on screening history: the NELSON lung cancer screening study.
    Thorax. 2017 Mar 30. pii: thoraxjnl-2016-209892.
    PubMed     Abstract available
    
    
    
92. MARSHALL HM, Zhao H, Bowman RV, Passmore LH, et al
    The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.
    Thorax. 2017 Mar 22. pii: thoraxjnl-2016-209624.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: